Atheroma and coronary bifurcations: before and after stenting.

First generation drug-eluting stents (DES) have significantly improved the treatment options for patients with symptomatic coronary artery disease by decreasing rates of restenosis after percutaneous coronary revascularisation procedures. However, early enthusiasm was tempered by reports of late stent thrombosis, primarily in "off-label" use. In particular, the treatment of atherosclerotic plaques at coronary bifurcations has been challenging for interventional cardiologists regardless of the stent choice due to the underlying nature of the atherosclerotic disease and the use of multiple stents. In this article we illustrate the location and severity of plaque and investigate the healing following both bare metal stents (BMS) and drug-eluting stents (DES) at bifurcations using post-mortem specimens. The presented data will demonstrate that neointimal growth following stent implantation correlate to flow conditions, as there is less underlying atherosclerotic disease at high shear regions and subsequently less neointimal growth is observed in these regions versus low shear regions. The occurrence of late stent thrombosis in DES is also shown to be associated with greater presence of uncovered stent struts at the high shear region, which is likely due to local flow mechanics.

[1]  Neville Kukreja,et al.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.

[2]  E. Edelman,et al.  Dynamic flow alterations dictate leukocyte adhesion and response to endovascular interventions. , 2004, The Journal of clinical investigation.

[3]  Michael Joner,et al.  Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[4]  M. Bell,et al.  Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. , 2000, Journal of the American College of Cardiology.

[5]  S. de Servi,et al.  Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS). , 2010, American heart journal.

[6]  Seung‐Jung Park,et al.  Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. , 2005, Journal of the American College of Cardiology.

[7]  Gregg W Stone,et al.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.

[8]  A. Farb,et al.  Stent thrombosis redux--the FDA perspective. , 2007, The New England journal of medicine.

[9]  F. Grosveld,et al.  Atherosclerotic Lesion Size and Vulnerability Are Determined by Patterns of Fluid Shear Stress , 2006, Circulation.

[10]  Renu Virmani,et al.  Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation. , 2010, Journal of the American College of Cardiology.

[11]  David G Rizik,et al.  Bifurcation coronary artery disease: current techniques and future directions (part 1). , 2008, The Journal of invasive cardiology.

[12]  D. Ku,et al.  Pulsatile Flow and Atherosclerosis in the Human Carotid Bifurcation: Positive Correlation between Plaque Location and Low and Oscillating Shear Stress , 1985, Arteriosclerosis.

[13]  D. Ku,et al.  Pulsatile flow in the human left coronary artery bifurcation: average conditions. , 1996, Journal of biomechanical engineering.

[14]  A. Svindland,et al.  Localization of atherosclerotic lesions in the bifurcation of the main left coronary artery. , 1983, Atherosclerosis.

[15]  Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. , 2005, Journal of the American College of Cardiology.

[16]  Antonio Colombo,et al.  Bifurcation disease: what do we know, what should we do? , 2008, JACC. Cardiovascular interventions.

[17]  M. H. Friedman,et al.  Influence of curvature dynamics on pulsatile coronary artery flow in a realistic bifurcation model. , 2004, Journal of biomechanics.

[18]  Antonio Colombo,et al.  Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions , 2004, Circulation.

[19]  A. Tzafriri,et al.  Strut Position, Blood Flow, and Drug Deposition: Implications for Single and Overlapping Drug-Eluting Stents , 2005, Circulation.

[20]  Rob Krams,et al.  Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. , 2005, Blood.

[21]  Imad Sheiban,et al.  Update on dedicated bifurcation stents. , 2009, Journal of interventional cardiology.

[22]  B. Berk,et al.  Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[23]  G. Hutchins,et al.  Correlation between wall shear and intimal thickness at a coronary artery branch. , 1987, Atherosclerosis.

[24]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[25]  Michael M. Resch,et al.  Pulsatile non-Newtonian blood flow in three-dimensional carotid bifurcation models: a numerical study of flow phenomena under different bifurcation angles. , 1991, Journal of biomedical engineering.

[26]  Young-Seok Cho,et al.  Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve. , 2008, European heart journal.

[27]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[28]  Johan Lindbäck,et al.  Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. , 2007, The New England journal of medicine.

[29]  I. Iakovou,et al.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.

[30]  Simon Wandel,et al.  Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis , 2007, The Lancet.

[31]  Samin K. Sharma,et al.  Coronary bifurcation lesions: a current update. , 2010, Cardiology clinics.

[32]  I. Seong,et al.  Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery Disease , 2006, Circulation.

[33]  B. Fox,et al.  Distribution of fatty and fibrous plaques in young human coronary arteries. , 1982, Atherosclerosis.